These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16377408)

  • 21. In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy.
    Kumar H; Bot A
    Int Rev Immunol; 2017 Jul; 36(4):205-206. PubMed ID: 28537793
    [No Abstract]   [Full Text] [Related]  

  • 22. Neoantigens in the immuno-oncology space.
    Arlen PM
    Future Oncol; 2017 Oct; 13(25):2209-2211. PubMed ID: 28976211
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trial.
    Kan N; Ohgaki K; Yamasaki N; Hori T; Nakayama N; Nio Y; Inamoto T; Hikasa Y
    Nihon Geka Hokan; 1983 Nov; 52(6):841-53. PubMed ID: 6380446
    [No Abstract]   [Full Text] [Related]  

  • 24. [A scientist's day-dream or future reality? Specific immunotherapy against cancer].
    Kiessling R; Kärre K
    Lakartidningen; 1997 Apr; 94(17):1595-600. PubMed ID: 9182159
    [No Abstract]   [Full Text] [Related]  

  • 25. Combining radiotherapy and cancer immunotherapy: a paradigm shift.
    Formenti SC; Demaria S
    J Natl Cancer Inst; 2013 Feb; 105(4):256-65. PubMed ID: 23291374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].
    Ikeda H; Shiku H
    Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study May Change Approach to Immunotherapy.
    Cancer Discov; 2016 May; 6(5):OF1. PubMed ID: 27012834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer immunotherapy using tumor cryoablation.
    Sidana A
    Immunotherapy; 2014; 6(1):85-93. PubMed ID: 24341887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
    Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
    Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
    [No Abstract]   [Full Text] [Related]  

  • 32. Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.
    Spagnoli GC; Ebrahimi M; Iezzi G; Mengus C; Zajac P
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):184-92. PubMed ID: 20205052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer immunotherapy.
    Falk RE
    Can Med Assoc J; 1979 Feb; 120(3):255, 258. PubMed ID: 311678
    [No Abstract]   [Full Text] [Related]  

  • 35. [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2536-44. PubMed ID: 9922678
    [No Abstract]   [Full Text] [Related]  

  • 36. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of neoantigens in response to immune checkpoint blockade.
    Riaz N; Morris L; Havel JJ; Makarov V; Desrichard A; Chan TA
    Int Immunol; 2016 Aug; 28(8):411-9. PubMed ID: 27048318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using monoclonal antibodies to stimulate antitumor cellular immunity.
    Durrant LG; Pudney VA; Spendlove I
    Expert Rev Vaccines; 2011 Jul; 10(7):1093-106. PubMed ID: 21806402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scientific contributions toward successful cancer immunotherapy in The Netherlands.
    Melief CJ; Scheper RJ; de Vries IJ
    Immunol Lett; 2014 Dec; 162(2 Pt B):121-6. PubMed ID: 25455598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.